医学
移植
标准化
临床试验
食品药品监督管理局
临床前研究
重症监护医学
转化研究
临床研究设计
药物开发
医学物理学
临床研究
生物信息学
风险分析(工程)
药品
病理
药理学
计算机科学
外科
操作系统
生物
作者
Paolo Cravedi,Leonardo V. Riella,Mandy L. Ford,Anna Valujskikh,Madhav C. Menon,Allan D. Kirk,Maria‐Luisa Alegre,Sandy Feng,Patricia Kehn,Nader Najafian,Wayne W. Hancock,Peter S. Heeger,Jonathan S. Maltzman,Roslyn B. Mannon,Satish N. Nadig,Jonah Odim,Hēth Turnquist,Julia M. Shaw,Lori J. West,Xunrong Luo,Anita S. Chong,Jonathan S. Bromberg
标识
DOI:10.1016/j.ajt.2024.01.006
摘要
Mouse models have been instrumental in understanding mechanisms of transplant rejection and tolerance, but cross-study reproducibility and translation of experimental findings into effective clinical therapies are issues of concern. The Mouse Models in Transplantation symposium gathered scientists and physician-scientists involved in basic and clinical research in transplantation to discuss the strengths and limitations of mouse transplant models and strategies to enhance their utility. Participants recognized that increased procedure standardization, including the use of prespecified, defined endpoints, and statistical power analyses, would benefit the field. They also discussed the generation of new models that incorporate environmental and genetic variables affecting clinical outcomes as potentially important. If implemented, these strategies are expected to improve the reproducibility of mouse studies and increase their translation to clinical trials and, ideally, new Food and Drug Administration-approved drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI